Home » Newsletters » The Carlat Psychiatry Report

The Carlat Psychiatry Report

Problems with Generics (May) | 2021

View Archived Issues

Learning Objectives, Problems with Generics, TCPR, May 2021

May 4, 2021

After reading these articles, you should be able to… Read More

In Brief: Lamotrigine Gets a New Warning

May 4, 2021

Chris Aiken, MD, and Sarah Rivelli, MD.

A new warning now sits beneath the list of life-threatening allergic reactions that can happen with lamotrigine. The anticonvulsant is suspected of causing cardiac arrhythmias in susceptible patients by slowing ventricular conduction and widening the QRS. Read More

A Review of Medications for PTSD, With a Focus on Topiramate

May 4, 2021

Paul Riordan, MD.

Topiramate is not first-line in PTSD, but it does have a role, particularly when alcohol use is part of the picture. Read More

What’s Wrong With Generics?

May 4, 2021

Katherine Eban

Generic recalls are on the rise: Bupropion, methylphenidate, and metformin, to name a few. Katherine Eban explains the limits of FDA oversight, and what we can do to protect our patients when quality control cones under suspicion. Read More

Depression, Vitamin D, and COVID-19

May 4, 2021

Paul Riordan, MD.

Vitamin D deficiency is causing everything from depression to cancer to COVID-19, at least that’s what our patients are hearing. Paul Riordan looks at the strength of that research and clarifies when to check levels and when to supplement. Read More

Maintenance Pharmacotherapy of Bipolar Disorder: How Long Is Long Enough?

May 4, 2021

Nicholas Rosenlicht, MD.

Textbooks tell us that patients with bipolar I disorder need to take mood stabilizers for life. But what are the real risks of stopping these medications? A new meta-analysis provides some clarity. Read More